The9 (NCTY) Q2 2026 Earnings Call Transcript

The9 Limited reported Q2 net income of $32M (+39% sequential), driven largely by a $47.2M fair value gain on its 9BIT token holdings, while first-half net income reached $55M. Revenue fell to $0.7M (-80.8% YoY) due to reduced Bitcoin mining activity, but the company expects The9bit revenue growth in 2H 2026 after launching in-game purchases for mid-core games. Separately, shareholders approved The9/Nanyang Biologics business combination, with The9 expecting a 15%-16% stake and NYB cap around $7.7B if RFAI’s share price holds—supporting anticipated future investment income.

Analysis

The market mechanism here is less “AI gaming” than a leveraged claim on two volatile marks: token inventory and a pending listed stake in NYB. That creates asymmetric upside in a momentum tape, but it also means reported earnings can decouple sharply from cash generation; once the token bid weakens, the income statement can look much worse than the operating narrative. The real winner, if this works, is not a traditional game publisher but any microcap with a liquid treasury and a credible way to reprice its balance sheet faster than fundamentals can catch up.

The second-order loser set is broader than the headline suggests. Incumbent UGC/game engines and creator monetization platforms face a “good enough + token incentives” challenger, but the bigger issue is that The9 is trying to internalize payments, distribution, and engagement economics inside one stack, which could compress third-party monetization opportunities. The flip side is that the company’s stated expansion into higher-CAC regions implies the next 1-3 months matter far more than the next 12 months: if paid user acquisition is not efficient outside Southeast Asia, the growth story remains a proof-of-concept, not a scalable platform.

Contrarian view: the consensus is likely over-weighting user counts and token price and under-weighting reflexivity risk. If 9BIT liquidity thins or the token retraces, the “investment income” narrative can reverse quickly, and the NYB stake may already be partly embedded in the equity. What would falsify the bullish thesis is a lack of sequential revenue inflection by late 2026, weaker token turnover, or any delay in the NYB listing that removes the clearest near-term mark-to-market catalyst.

Key Decisions for Investors

• Short NCTY on strength or through a small call spread hedge over the next 2-6 weeks; this is a quality-of-earnings short with upside capped by token volatility, but the thesis breaks if Q3/Q4 revenue inflects materially and token daily volume stays near current levels.
• Event-driven long RFAI only if NASDAQ approval is confirmed and the closing window tightens; this is the cleaner expression of the NYB rerating, but size modestly because any SPAC process delay can mean sharp multiple compression.
• Avoid chasing EQIX, NVDA, or HPQ on the stated partnership halo; there is no visible financial transmission yet, so those are watchlist names only unless disclosed revenue or infrastructure spend emerges.
• Set an alert on 9BIT token liquidity and price rather than NCTY headline earnings; a sustained break in token turnover or a 30%+ drawdown would be the best early warning that reported income quality is deteriorating.
• If long NCTY for optionality, pair it against a short in a more mature gaming/UGC proxy rather than a broad market short; the core risk is idiosyncratic reflexivity, not beta.